Felix Mahfoud
#141,199
Most Influential Person Now
Researcher
Felix Mahfoud's AcademicInfluence.com Rankings
Felix Mahfoudengineering Degrees
Engineering
#5287
World Rank
#6536
Historical Rank
Electrical Engineering
#1458
World Rank
#1552
Historical Rank
Felix Mahfoudcomputer-science Degrees
Computer Science
#6782
World Rank
#7147
Historical Rank
Data Science
#136
World Rank
#139
Historical Rank
Computational Linguistics
#1246
World Rank
#1260
Historical Rank
Machine Learning
#2315
World Rank
#2343
Historical Rank
Download Badge
Engineering Computer Science
Felix Mahfoud's Degrees
- PhD Computer Science Stanford University
- Masters Electrical Engineering University of California, Berkeley
- Bachelors Mathematics University of California, Berkeley
Similar Degrees You Can Earn
Why Is Felix Mahfoud Influential?
(Suggest an Edit or Addition)Felix Mahfoud's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- 2018 ESC/ESH Guidelines for the management of arterial hypertension. (2018) (5481)
- 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. (2020) (3083)
- [2018 ESC/ESH Guidelines for the management of arterial hypertension]. (2019) (2445)
- [2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)]. (2018) (1684)
- Effect of Renal Sympathetic Denervation on Glucose Metabolism in Patients With Resistant Hypertension: A Pilot Study (2011) (582)
- Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study (2014) (577)
- Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial (2017) (503)
- Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial (2018) (486)
- Update on myocarditis. (2012) (485)
- 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH/ESC Task Force for the Management of Arterial Hypertension. (2018) (476)
- Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial (2018) (413)
- Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. (2012) (378)
- Renal denervation in moderate to severe CKD. (2012) (360)
- Comparative Evaluation of Left and Right Ventricular Endomyocardial Biopsy: Differences in Complication Rate and Diagnostic Performance (2010) (341)
- Renal Hemodynamics and Renal Function After Catheter-Based Renal Sympathetic Denervation in Patients With Resistant Hypertension (2012) (305)
- Ambulatory Blood Pressure Changes After Renal Sympathetic Denervation in Patients With Resistant Hypertension (2013) (257)
- 2018 Practice guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension (2018) (254)
- Expert consensus document from the European Society of Cardiology on catheter-based renal denervation. (2013) (252)
- Renal sympathetic denervation for treatment of electrical storm: first-in-man experience (2011) (233)
- Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial. (2014) (230)
- Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials (2017) (228)
- Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial (2020) (217)
- Renal Sympathetic Denervation Suppresses Postapneic Blood Pressure Rises and Atrial Fibrillation in a Model for Sleep Apnea (2012) (210)
- Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial (2018) (191)
- Sympatho-renal axis in chronic disease (2011) (178)
- First Report of the Global SYMPLICITY Registry on the Effect of Renal Artery Denervation in Patients With Uncontrolled Hypertension (2015) (176)
- Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design. (2015) (175)
- Prognostic electrocardiographic parameters in patients with suspected myocarditis (2011) (166)
- Impact of Lesion Placement on Efficacy and Safety of Catheter-Based Radiofrequency Renal Denervation. (2015) (162)
- Virus serology in patients with suspected myocarditis: utility or futility? (2011) (162)
- Cardiorespiratory response to exercise after renal sympathetic denervation in patients with resistant hypertension. (2011) (150)
- Renal denervation: a potential new treatment modality for polycystic ovary syndrome? (2011) (148)
- Effects of renal sympathetic denervation on arterial stiffness and central hemodynamics in patients with resistant hypertension. (2012) (147)
- Device-Based Antihypertensive Therapy: Therapeutic Modulation of the Autonomic Nervous System (2011) (145)
- Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease. (2013) (145)
- Effects of renal sympathetic denervation on heart rate and atrioventricular conduction in patients with resistant hypertension. (2013) (144)
- Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry (2019) (142)
- Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial. (2014) (139)
- International expert consensus statement: Percutaneous transluminal renal denervation for the treatment of resistant hypertension. (2013) (138)
- Renal denervation suppresses ventricular arrhythmias during acute ventricular ischemia in pigs. (2013) (136)
- The SPYRAL HTN Global Clinical Trial Program: Rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medications. (2016) (127)
- ESC Council on hypertension position document on the management of hypertensive emergencies. (2018) (126)
- Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the Global SYMPLICITY Registry (2016) (125)
- Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk. (2021) (124)
- Atrial autonomic innervation: a target for interventional antiarrhythmic therapy? (2014) (121)
- Effect of Renal Denervation on Neurohumoral Activation Triggering Atrial Fibrillation in Obstructive Sleep Apnea (2013) (119)
- Improvements in left ventricular hypertrophy and diastolic function following renal denervation: effects beyond blood pressure and heart rate reduction. (2014) (117)
- Innervation patterns may limit response to endovascular renal denervation. (2014) (116)
- Renal Sympathetic Denervation Provides Ventricular Rate Control But Does Not Prevent Atrial Electrical Remodeling During Atrial Fibrillation (2013) (112)
- Renal denervation in moderate treatment-resistant hypertension. (2013) (111)
- Reduced Effect of Percutaneous Renal Denervation on Blood Pressure in Patients With Isolated Systolic Hypertension (2015) (106)
- The autonomic nervous system as a therapeutic target in heart failure: a scientific position statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology (2017) (100)
- Renal denervation preserves renal function in patients with chronic kidney disease and resistant hypertension (2015) (98)
- Proceedings from the 2nd European Clinical Consensus Conference for device-based therapies for hypertension: state of the art and considerations for the future (2017) (93)
- Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial (2021) (93)
- Cognitive function in patients with decompensated heart failure: the Cognitive Impairment in Heart Failure (CogImpair‐HF) study (2012) (89)
- Invasive left ventricle pressure–volume analysis: overview and practical clinical implications (2019) (85)
- 6-Month Outcomes in Patients With Implantable Cardioverter-Defibrillators Undergoing Renal Sympathetic Denervation for the Treatment of Refractory Ventricular Arrhythmias. (2015) (78)
- Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120–140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials (2018) (78)
- Renal nerve ablation reduces augmentation index in patients with resistant hypertension (2013) (77)
- Renal nerve ablation after SYMPLICITY HTN-3: confused at the higher level? (2014) (75)
- The cardiopulmonary continuum systemic inflammation as 'common soil' of heart and lung disease. (2010) (74)
- Renal sympathetic denervation: applications in hypertension and beyond (2013) (74)
- Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control Following Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO Trial. (2019) (73)
- Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis (2015) (72)
- Catheter-based renal denervation is no simple matter: lessons to be learned from our anatomy? (2014) (72)
- Renal denervation for the treatment of cardiovascular high risk-hypertension or beyond? (2014) (70)
- Improvement of albuminuria after renal denervation. (2014) (70)
- Renal denervation for treatment of ventricular arrhythmias: data from an International Multicenter Registry (2016) (68)
- Catheter-based renal nerve ablation and centrally generated sympathetic activity in difficult-to-control hypertensive patients: prospective case series. (2013) (67)
- Renal denervation: symply trapped by complexity? (2015) (64)
- Catheter-Based Renal Denervation Reduces Atrial Nerve Sprouting and Complexity of Atrial Fibrillation in Goats (2015) (62)
- Rationale and design of a large registry on renal denervation: the Global SYMPLICITY registry. (2013) (62)
- Diagnostic and prognostic validity of different biomarkers in patients with suspected myocarditis (2014) (58)
- Survival After Coronary Revascularization With Paclitaxel-Coated Balloons. (2020) (56)
- Blood Pressure Response to Main Renal Artery and Combined Main Renal Artery Plus Branch Renal Denervation in Patients With Resistant Hypertension (2017) (56)
- Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension (2016) (55)
- Renal denervation and heart failure (2014) (55)
- Arterial microanatomy determines the success of energy-based renal denervation in controlling hypertension (2015) (55)
- Drug adherence in patients taking oral anticoagulation therapy (2014) (54)
- Ambulatory heart rate reduction after catheter-based renal denervation in hypertensive patients not receiving anti-hypertensive medications: data from SPYRAL HTN-OFF MED, a randomized, sham-controlled, proof-of-concept trial (2019) (54)
- Progression of kidney injury and cardiac remodeling in obese spontaneously hypertensive rats: the role of renal sympathetic innervation. (2015) (53)
- Renal Denervation Update From the International Sympathetic Nervous System Summit: JACC State-of-the-Art Review. (2019) (53)
- A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs. (2018) (53)
- Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies (2020) (52)
- Effects of Electrical Stimulation of Carotid Baroreflex and Renal Denervation on Atrial Electrophysiology (2013) (52)
- Renal Denervation for Treating Hypertension: Current Scientific and Clinical Evidence. (2019) (51)
- Treatment strategies for resistant arterial hypertension. (2011) (48)
- Alcohol-Mediated Renal Denervation Using the Peregrine System Infusion Catheter for Treatment of Hypertension. (2020) (48)
- What the interventionalist should know about renal denervation in hypertensive patients: a position paper by the ESH WG on the interventional treatment of hypertension. (2014) (48)
- Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial (2020) (47)
- Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study (2019) (46)
- FGF-23 is associated with increased disease severity and early mortality in cardiogenic shock (2013) (45)
- Renal Denervation in High-Risk Patients With Hypertension. (2020) (45)
- Atrial Remodeling Following Catheter-Based Renal Denervation Occurs in a Blood Pressure- and Heart Rate-Independent Manner. (2015) (44)
- Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial (2022) (43)
- Blood pressure changes after catheter-based renal denervation are related to reductions in total peripheral resistance (2015) (43)
- European Society of Hypertension position paper on renal denervation 2021. (2021) (43)
- Device-based therapies for arterial hypertension (2020) (43)
- Effects of renal sympathetic denervation on urinary sodium excretion in patients with resistant hypertension (2015) (42)
- Effect of obstructive respiratory events on blood pressure and renal perfusion in a pig model for sleep apnea. (2014) (42)
- Beneficial effects of renal sympathetic denervation on cardiovascular inflammation and remodeling in essential hypertension (2015) (41)
- Atrial fibrillation and gastroesophageal reflux disease: the cardiogastric interaction (2016) (41)
- Changes in Plasma Renin Activity after Renal Artery Sympathetic Denervation. (2021) (41)
- Decline of emergency admissions for cardiovascular and cerebrovascular events after the outbreak of COVID-19 (2020) (40)
- The AFR-PRELIEVE TRIAL A prospective, non-randomized, pilot study to assess the Atrial Flow Regulator (AFR) in Heart Failure Patients with either preserved or reduced ejection fraction. (2019) (40)
- LONG-TERM FOLLOW-UP OF CATHETER-BASED RENAL SYMPATHETIC DENERVATION FOR RESISTANT HYPERTENSION CONFIRMS DURABLE BLOOD PRESSURE REDUCTION (2012) (38)
- Angiopoietin-2 and outcome in patients with acute decompensated heart failure (2015) (38)
- Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studies (2015) (38)
- Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk. (2019) (37)
- The biophysics of renal sympathetic denervation using radiofrequency energy (2014) (37)
- European Society of Hypertension position paper on renal denervation 2018. (2018) (37)
- Renal sympathetic nerve denervation using intraluminal ultrasound within a cooling balloon preserves the arterial wall and reduces sympathetic nerve activity. (2015) (36)
- Device-based Therapy for Hypertension (2016) (36)
- Obstructive respiratory events and premature atrial contractions after cardioversion (2015) (36)
- [Expert consensus statement on interventional renal sympathetic denervation for hypertension treatment]. (2011) (36)
- Response and non-response to renal denervation: who is the ideal candidate? (2013) (36)
- Hypo- and hyperglycemia predict outcome in patients with left ventricular dysfunction after acute myocardial infarction: data from EPHESUS. (2012) (35)
- Renal denervation: effects on atrial electrophysiology and arrhythmias (2014) (33)
- Intracranial pressure pulse amplitude during changes in head elevation: a new parameter for determining optimum cerebral perfusion pressure? (2010) (33)
- Catheter-based renal denervation: the black box procedure. (2013) (32)
- Empagliflozin Improves Cardiovascular and Renal Outcomes in Heart Failure Irrespective of Systolic Blood Pressure. (2021) (32)
- Orthostatic function after renal sympathetic denervation in patients with resistant hypertension. (2013) (32)
- Heart-focused anxiety in the general population (2012) (32)
- From SYMPLICITY HTN-3 to the renal denervation global registry: where do we stand and where should we go? (2014) (31)
- Effects of Renal Sympathetic Denervation on Exercise Blood Pressure, Heart Rate, and Capacity in Patients With Resistant Hypertension (2014) (30)
- Low‐Level But Not High‐Level Baroreceptor Stimulation Inhibits Atrial Fibrillation in a Pig Model of Sleep Apnea (2016) (30)
- Myocardial reperfusion reverses the J-curve association of cardiovascular risk and diastolic blood pressure in patients with left ventricular dysfunction and heart failure after myocardial infarction: insights from the EPHESUS trial. (2020) (30)
- Resting heart rate and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk analysis from the ONTARGET/TRANSCEND trials. (2020) (29)
- Anxiety, depression, quality of life and stress in patients with resistant hypertension before and after catheter-based renal sympathetic denervation. (2013) (29)
- 12-Month Results From the Unblinded Phase of the RADIANCE-HTN SOLO Trial of Ultrasound Renal Denervation. (2020) (28)
- The non-steroidal mineralocorticoid receptor antagonist finerenone prevents cardiac fibrotic remodeling. (2019) (27)
- [Dialysis and ultrafiltration therapy in patients with cardio-renal syndrome: recommendations of the working group "heart-kidney" of the German Cardiac Society and the German Society of Nephrology]. (2014) (27)
- Twenty-Four-Hour Ambulatory Blood Pressure Reduction Patterns After Renal Denervation in the SPYRAL HTN-OFF MED Trial. (2018) (27)
- TCT-12 Long-term Follow-up of Catheter-based Renal Denervation For Resistant Hypertension Confirms Durable Blood Pressure Reduction (2012) (26)
- Renal denervation for treatment of uncontrolled hypertension in an Asian population: results from the Global SYMPLICITY Registry in South Korea (GSR Korea) (2016) (25)
- The Sympathetic Nervous System in Chronic Kidney Disease (2013) (25)
- Bare metal or drug-eluting stent versus drug-coated balloon in non-ST-elevation myocardial infarction: the randomised PEPCAD NSTEMI trial (2020) (24)
- Effect of Arteriovenous Anastomosis on Blood Pressure Reduction in Patients With Isolated Systolic Hypertension Compared With Combined Hypertension (2016) (24)
- Design Considerations for Clinical Trials of Autonomic Modulation Therapies Targeting Hypertension and Heart Failure (2015) (24)
- Blood pressure variability after catheter-based renal sympathetic denervation in patients with resistant hypertension (2015) (24)
- Analyses of drugs stored at home by elderly patients with chronic heart failure (2015) (23)
- One‐year results of the first‐in‐man study investigating the Atrial Flow Regulator for left atrial shunting in symptomatic heart failure patients: the PRELIEVE study (2021) (22)
- Cardiac remodeling and myocardial dysfunction in obese spontaneously hypertensive rats (2012) (22)
- Effects of Arteriovenous Fistula on Blood Pressure in Patients With End‐Stage Renal Disease: A Systematic Meta‐Analysis (2019) (22)
- Non‐adherence to ivabradine and placebo and outcomes in chronic heart failure: an analysis from SHIFT (2016) (22)
- Microalbuminuria independently correlates to cardiovascular comorbidity burden in patients with hypertension (2012) (22)
- Comparison of branch and distally focused main renal artery denervation using two different radio-frequency systems in a porcine model. (2017) (21)
- THE EUROPEAN/INTERNATIONAL FIBROMUSCULAR DYSPLASIA REGISTRY AND INITIATIVE (FEIRI)- CLINICAL PHENOTYPES AND THEIR PREDICTORS BASED ON A COHORT OF ONE THOUSAND PATIENTS. (2020) (21)
- Effects of face masks on performance and cardiorespiratory response in well-trained athletes (2021) (21)
- Modulation of renal sympathetic innervation: recent insights beyond blood pressure control (2018) (21)
- Ventricular arrhythmias and myocardial inflammation: Long-term follow-up of patients with suspected myocarditis. (2019) (21)
- Potential role of renal sympathetic denervation for the treatment of cardiac arrhythmias. (2013) (21)
- Hypertension: history and development of established and novel treatments (2018) (20)
- Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting (2021) (20)
- One-year clinical outcomes in patients with renal insufficiency after contemporary PCI: data from a multicenter registry (2019) (20)
- Effect of Visit‐to‐Visit Variation of Heart Rate and Systolic Blood Pressure on Outcomes in Chronic Systolic Heart Failure: Results From the Systolic Heart Failure Treatment With the I f Inhibitor Ivabradine Trial (SHIFT) Trial (2016) (20)
- Percutaneous renal denervation: new treatment option for resistant hypertension and more? (2013) (20)
- Neuropeptide Y as an indicator of successful alterations in sympathetic nervous activity after renal sympathetic denervation (2015) (20)
- Catheter-based renal denervation: the next chapter begins. (2018) (20)
- Safety and performance of diagnostic electrical mapping of renal nerves in hypertensive patients. (2018) (20)
- Impact of obstructive and central apneas on ventricular repolarisation: lessons learned from studies in man and pigs (2016) (20)
- Renal denervation reduces office and ambulatory heart rate in patients with uncontrolled hypertension: 12-month outcomes from the global SYMPLICITY registry (2016) (19)
- Confounding Factors in Renal Denervation Trials: Revisiting Old and Identifying New Challenges in Trial Design of Device Therapies for Hypertension. (2020) (19)
- Renal denervation in hypertensive patients not on blood pressure lowering drugs (2016) (19)
- Interpreting treatment-induced blood pressure reductions measured by ambulatory blood pressure monitoring (2013) (19)
- Renal sympathetic denervation increases urinary sodium excretion in patients with treatment resistant hypertension (2013) (19)
- Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial (2022) (19)
- Catheter-based radio-frequency renal nerve denervation lowers blood pressure in obese hypertensive swine model (2016) (19)
- Renal artery denervation for treatment of patients with self-reported obstructive sleep apnea and resistant hypertension: results from the Global SYMPLICITY Registry (2017) (19)
- Association of vitamin D status and blood pressure response after renal denervation (2013) (18)
- Hypertension up to date: SPRINT to SPYRAL (2017) (18)
- Effect of Heart Rate on the Outcome of Renal Denervation in Patients With Uncontrolled Hypertension. (2021) (18)
- Procedural and Anatomical Determinants of Multielectrode Renal Denervation Efficacy. (2019) (18)
- Association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk (2018) (18)
- Renal sympathetic denervation restores aortic distensibility in patients with resistant hypertension: data from a multi-center trial (2018) (18)
- The 2018 ESC/ESH Guidelines for the management of arterial hypertension: A German point of view. (2019) (18)
- Cardiovascular outcomes, bleeding risk, and achieved blood pressure in patients on long-term anticoagulation with the thrombin antagonist dabigatran or warfarin: data from the RE-LY trial. (2020) (17)
- Expanding the indication spectrum: renal denervation in diabetes. (2013) (17)
- Azilsartan compared to ACE inhibitors in anti-hypertensive therapy: one-year outcomes of the observational EARLY registry (2016) (17)
- Randomized Comparison of Bare Metal or Drug-Eluting Stent versus Drug Coated Balloon in Non-ST-Elevation Myocardial Infarction - PEPCAD NSTEMI. (2019) (17)
- Catheter-based renal denervation as adjunct to pulmonary vein isolation for treatment of atrial fibrillation: a systematic review and meta-analysis. (2020) (17)
- Changes in 24-Hour Patterns of Blood Pressure in Hypertension Following Renal Denervation Therapy (2019) (16)
- Echocardiographic criteria to detect unicuspid aortic valve morphology (2019) (16)
- Heart failure and renal outcomes according to baseline and achieved blood pressure in patients with type 2 diabetes: results from EMPA-REG OUTCOME. (2020) (16)
- Heart rate and blood pressure interactions in the development of erectile dysfunction in high-risk cardiovascular patients (2014) (16)
- Rationale and design of two randomized sham-controlled trials of catheter-based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN-OFF MED Pivotal) and presence (SPYRAL HTN-ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design (2020) (16)
- Treating resistant hypertension: role of renal denervation (2013) (16)
- New Drugs and Technologies Device-Based Antihypertensive Therapy Therapeutic Modulation of the Autonomic Nervous System (2011) (15)
- Anatomical and procedural determinants of catheter-based renal denervation. (2016) (15)
- Renal artery anatomy assessed by quantitative analysis of selective renal angiography in 1,000 patients with hypertension. (2018) (15)
- Impact of angiotensin receptor blocker product recalls on antihypertensive prescribing in Germany (2020) (15)
- Efficacy and Safety of Catheter-Based Radiofrequency Renal Denervation in Stented Renal Arteries (2014) (15)
- Device Therapy of Hypertension (2021) (15)
- Renal denervation in patients with versus without chronic kidney disease: results from the global SYMPLICITY Registry with follow-up data of 3 years. (2021) (15)
- Arterial hypertension – Clinical trials update 2021 (2021) (15)
- Therapeutic potential of renal sympathetic denervation in patients with chronic heart failure. (2013) (14)
- Interventional closure vs. medical therapy of patent foramen ovale for secondary prevention of stroke: updated meta-analysis (2018) (14)
- From Evidence to Rationale: Cardiovascular Protection by Angiotensin II Receptor Blockers Compared with Angiotensin-Converting Enzyme Inhibitors (2010) (14)
- Contemporary scientometric analyses using a novel web application: the science performance evaluation (SciPE) approach (2019) (14)
- Blood pressure and heart rate predict outcome in patients acutely admitted with suspected myocarditis without previous heart failure (2012) (14)
- Development and application of a LC-HRMS/MS method for analyzing antihypertensive drugs in oral fluid for monitoring drug adherence. (2019) (13)
- The association between different features of sleep‐disordered breathing and blood pressure: A cross‐sectional study (2018) (13)
- Renal Denervation for Chronic Heart Failure: Background and Pathophysiological Rationale (2016) (12)
- Effects of renal denervation on 24-h heart rate and heart rate variability in resistant hypertension (2019) (12)
- Sex differences in arterial hypertension (2022) (11)
- Recent advances in the treatment of hypertension (2011) (11)
- Catheter-based renal denervation: a word of caution. (2013) (11)
- Modulation of the sympathetic nervous system by renal denervation prevents reduction of aortic distensibility in atherosclerosis prone ApoE-deficient rats (2016) (11)
- [Baroreceptor activation therapy for therapy-resistant hypertension: indications and patient selection : Recommendations of the BAT consensus group 2017]. (2017) (11)
- Physiologically Based Pharmacokinetic Modeling of Metoprolol Enantiomers and α-Hydroxymetoprolol to Describe CYP2D6 Drug-Gene Interactions (2020) (11)
- Aldosterone antagonists and renal denervation: friends or foes? (2015) (10)
- Research in Atrial Fibrillation: A Scientometric Analysis Using the Novel Web Application SciPE. (2020) (10)
- Effect of renal denervation in attenuating the stress of morning surge in blood pressure: post-hoc analysis from the SPYRAL HTN-ON MED trial (2020) (10)
- Smoking is associated with a high prevalence of microalbuminuria in hypertensive high-risk patients: data from I-SEARCH (2010) (10)
- Procedural and anatomical predictors of renal denervation efficacy using two radiofrequency renal denervation catheters in a porcine model (2018) (10)
- [Interventional renal sympathetic denervation - a new approach for patients with resistant hypertension]. (2010) (10)
- The effect of renal denervation in moderate treatment-resistant hypertension with confirmed medication adherence (2016) (10)
- The current status of renal denervation for the treatment of arterial hypertension. (2021) (10)
- Effect of renal sympathetic denervation on short-term blood pressure variability in resistant hypertension: a meta-analysis (2017) (9)
- Renal Denervation Therapy: Can it Contribute to Better Blood Pressure Control in Hypertension? (2017) (9)
- [Anticoagulation in patients with chronic kidney disease : Recommendations from the working group "Heart-Kidney" of the German Cardiac Society and the German Society of Nephrology]. (2017) (9)
- Looking back and thinking forwards — 15 years of cardiology and cardiovascular research (2019) (9)
- Feasibility and efficacy of transcatheter interatrial shunt devices for chronic heart failure: a systematic review and meta‐analysis (2021) (9)
- ST-elevation during biventricular pacing. (2012) (9)
- Patients With Newly Diagnosed Hypertension Treated With the Renin Angiotensin Receptor Blocker Azilsartan Medoxomil vs Angiotensin‐Converting Enzyme Inhibitors: The Prospective EARLY Registry (2015) (9)
- TCT-761 Long-term (3-year) safety and effectiveness from the Global SYMPLICITY Registry of renal denervation in a real world patient population with uncontrolled hypertension. (2016) (9)
- Inadequate Reporting of Concomitant Drug Treatment in Cardiovascular Interventional Head‐to‐Head Trials (2012) (9)
- 1416Transvenous carotid body ablation for resistant hypertension: main results of a multicentre safety and proof-of-principle cohort study (2018) (9)
- Randomized trials of invasive cardiovascular interventions that include a placebo control: a systematic review and meta-analysis. (2020) (9)
- [Comorbidity: anemia and heart failure]. (2009) (9)
- Real-time left ventricular pressure-volume loops during percutaneous central arteriovenous anastomosis. (2018) (9)
- Catheter-based alcohol-mediated renal denervation for the treatment of uncontrolled hypertension: design of two sham-controlled, randomized, blinded trials in the absence (TARGET BP OFF-MED) and presence (TARGET BP I) of antihypertensive medications. (2021) (9)
- Anatomical and procedural determinants of ambulatory blood pressure lowering following catheter-based renal denervation using radiofrequency. (2018) (9)
- Research Output and International Cooperation Among Countries During the COVID-19 Pandemic: Scientometric Analysis (2020) (8)
- Witnessed drug intake before planned denervation--always harmless? (2015) (8)
- SYMPLICITY HTN-3 trial: what is it and what does it mean? (2014) (8)
- Hotlines and clinical trial updates presented at the European Society of Cardiology Meeting 2009: data from RE-LY, PLATO, MADIT-CRT, PROTECT, SYNTAX, TRITON and more (2009) (8)
- Physical activity is inversely associated with microalbuminuria in hypertensive patients at high cardiovascular risk: data from I-SEARCH (2012) (8)
- Drug-Coated Balloon for Small Coronary Artery Disease in Patients With and Without High-Bleeding Risk in the BASKET-SMALL 2 Trial (2022) (8)
- Hypertension trials update (2021) (8)
- Empagliflozin Improves Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Irrespective of Age. (2022) (8)
- Improvement in health‐related quality of life after renal sympathetic denervation in real‐world hypertensive patients: 12‐month outcomes in the Global SYMPLICITY Registry (2017) (8)
- Renal Denervation in the Treatment of Hypertension (2013) (8)
- Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium (2022) (8)
- Cardiovascular effects of waterpipe smoking: a systematic review and meta-analysis. (2020) (7)
- Prioritized Endpoints for Device-Based Hypertension Trials: the Win Ratio Methodology. (2020) (7)
- Renal denervation: expanding the indication. (2013) (7)
- Evaluating the importance of sham-controlled trials in the investigation of medical devices in interventional cardiology. (2018) (7)
- Renal Denervation: Is It Ready for Prime Time? (2019) (7)
- Thrombosis of TAVI prosthesis—cause for concern or innocent bystander? A comment and review of currently available data (2017) (7)
- Revaskularisation der Nierenarterienstenose: State of the Art (2012) (7)
- Predictors of blood pressure response to ultrasound renal denervation in the RADIANCE-HTN SOLO study (2021) (7)
- Renal nerve ablation (2014) (7)
- Association of clinic and ambulatory heart rate parameters with mortality in hypertension. (2020) (7)
- Safety and efficacy of endovascular ultrasound renal denervation in resistant hypertension: 12-month results from the ACHIEVE study. (2019) (7)
- Changes in Stroke Volume After Renal Denervation (2020) (6)
- Impact of number of prescribed medications on visit-to-visit variability of blood pressure: implications for design of future trials of renal denervation (2015) (6)
- Valvular heart disease in patients with chronic kidney disease (2021) (6)
- Remote Monitoring with Appropriate Reaction to Alerts Was Associated with Improved Outcomes in Chronic Heart Failure: Results from the OptiLink HF Study. (2020) (6)
- Sub-acute Safety and Efficacy Evaluation of Single versus Double Treatment Cycles of a Monopolar Radiofrequency Catheter-Based Renal Nerve Ablation and its Chronic Evolution in a Large Animal Model (2016) (6)
- TCT-423 The Paradise Renal Denervation System: Initial Clinical Results from the ACHIEVE Study (2014) (6)
- Novel and Nonpharmacologic Approaches to Cardio-Protection in Hypertension (2014) (6)
- Blood pressure targets in the elderly: many guidelines, much confusion. (2019) (6)
- Effects of renal denervation on atrial arrhythmogenesis. (2014) (6)
- The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry (2015) (6)
- Sympathoadrenergic suppression improves heart function by upregulating the ratio of sRAGE/RAGE in hypertension with metabolic syndrome. (2018) (6)
- Catheter-based Renal Sympathetic Denervation - Long-term Symplicity™ Renal Denervation Clinical Evidence, New Data and Future Perspectives. (2013) (6)
- Adherence to Antihypertensive Drugs Assessed by Hyphenated High‐Resolution Mass Spectrometry Analysis of Oral Fluids (2020) (6)
- RENAL DENERVATION IMPROVES GLUCOSE METABOLISM IN PATIENTS WITH RESISTANT HYPERTENSION: 5A.02 (2010) (6)
- Evaluation and analytical applicability of a novel volumetric absorptive microsampling strategy for adherence monitoring of antihypertensive drugs by means of LC-HRMS/MS. (2021) (5)
- Mitral valve pressure gradient after percutaneous mitral valve repair: every beat counts (2017) (5)
- Registration of Image Modalities for Analyses of Tissue Samples Using 3D Image Modelling (2020) (5)
- Renal Denervation: A Novel Non-pharmacological Approach in Heart Failure (2014) (5)
- Secretory Capacity of Pancreatic Beta-Cells Is Enhanced 6 Months After Renal Denervation in Hypertensive Patients. (2018) (5)
- REDUCED BLOOD PRESSURE LOWERING EFFECT OF CATHETER-BASED RENAL DENERVATION IN PATIENTS WITH ISOLATED SYSTOLIC HYPERTENSION: DATA FROM POOLED SYMPLICITY HTN TRIALS (2015) (5)
- Side effects and treatment initiation barriers of sodium–glucose cotransporter 2 inhibitors in heart failure: a systematic review and meta‐analysis (2022) (5)
- Treatment of hypertension in the elderly: data from an international cohort of hypertensives treated by cardiologists (2013) (5)
- EARLY Treatment with azilsartan compared to ACE-inhibitors in anti-hypertensive therapy – rationale and design of the EARLY hypertension registry (2013) (5)
- Long-term reduction in morning and nighttime blood pressure after renal denervation: 36-month results from SPYRAL HTN-ON MED trial (2022) (5)
- Peripheral edema and headache associated with amlodipine treatment: a meta-analysis of randomized, placebo-controlled trials. (2019) (5)
- First-in-human experience: percutaneous renal denervation through a false lumen fenestration in aortic dissection type B. (2013) (5)
- [Renal sympathetic denervation. A novel interventional treatment option for therapy-resistant arterial hypertension]. (2011) (5)
- [Comments on the guidelines (2018) of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH) on the management of arterial hypertension]. (2019) (5)
- Sunday, 26 August 2012 (2012) (5)
- Device-related risk of atrial fibrillation after closure of patent foramen ovale: a systematic review and meta-analysis (2021) (4)
- Cardiovascular Risk Reduction After Renal Denervation According to Time in Therapeutic Systolic Blood Pressure Range. (2022) (4)
- [Valvular heart disease in patients with chronic kidney disease]. (2020) (4)
- Secondary rise in blood pressure and leg swelling after central arteriovenous anastomosis (2018) (4)
- Twenty-Four-Hour Pulsatile Hemodynamics Predict Brachial Blood Pressure Response to Renal Denervation in the SPYRAL HTN-OFF MED Trial (2022) (4)
- [Chronic heart failure : current guideline recommendations and innovations]. (2015) (4)
- Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI). (2023) (4)
- Long-Term Results up to 12 Months After Catheter-Based Alcohol-Mediated Renal Denervation for Treatment of Resistant Hypertension (2021) (4)
- SPYRAL HTN-OFF MED TRIAL: CHANGES IN OFFICE AND AMBULATORY HEART RATE (2018) (4)
- [Therapy of hypertension--2015]. (2015) (4)
- Drug adherence and psychosocial characteristics of patients presenting with hypertensive urgency at the emergency department (2021) (4)
- Assessing Adherence to Antihypertensive Medication by Means of Dose-Dependent Reference Plasma Concentration Ranges and Ultra-High Performance Liquid Chromatography-Ion Trap Mass Spectrometry Analysis (2021) (4)
- [Contrast medium-induced acute kidney injury-Consensus paper of the working group "Heart and Kidney" of the German Cardiac Society and the German Society of Nephrology]. (2020) (4)
- [Heart and kidneys. Renal denervation as therapy for hypertension]. (2013) (4)
- Catheter-based renal denervation in hypertension: heading for new shores. (2018) (4)
- Kidney injury as post-interventional complication of TAVI (2020) (4)
- Long-Term Follow-Up of Baroreflex Activation Therapy in Resistant Hypertension: Another Piece of the Puzzle? (2017) (4)
- 4A.01: LONG-TERM EFFECTS OF RENAL ARTERY DENERVATION IN REAL WORLD PATIENTS WITH UNCONTROLLED HYPERTENSION FROM THE GLOBAL SYMPLICITY REGISTRY (2015) (4)
- Abbreviated Antiplatelet Therapy After Coronary Stenting in Patients With Myocardial Infarction at High Bleeding Risk. (2022) (4)
- The vulnerable myocardium: long-QT syndrome in Tako-Tsubo cardiomyopathy (2009) (4)
- CardioPulse. Catheter-based renal denervation for hypertension treatment: update 2015. (2016) (4)
- "Dear Doctor" Warning Letter (Rote-Hand-Brief) on Hydrochlorothiazide and Its Impact on Antihypertensive Prescription. (2020) (4)
- Cardiovascular protection: a breakthrough for high-risk patients (2009) (4)
- SARS-CoV-2 and COVID-19: a scientometric analysis of research output and international cooperation. (2020) (4)
- Research Output and International Cooperation Among Countries During the COVID-19 Pandemic: Scientometric Analysis (Preprint) (2020) (4)
- [Cardiovascular pharmacotherapy and coronary revascularization in end-stage renal failure]. (2019) (4)
- Adequate contacts after remote monitoring alerts were associated with improved outcomes in chronic heart failure: results from the OptiLink HF study (2020) (4)
- Accuracy of pulse rate derived from 24-h ambulatory blood pressure monitoring compared with heart rate from 24-h Holter-ECG. (2020) (3)
- Drug-coated balloons for small coronary artery disease in patients with chronic kidney disease: a pre-specified analysis of the BASKET-SMALL 2 trial (2022) (3)
- Where is renal nerve ablation going? (2020) (3)
- Heart failure outcomes according to heart rate and effects of empagliflozin in patients of the EMPEROR‐Preserved trial (2022) (3)
- Stereotactic Radiotherapy for Renal Denervation: To Beam, or Not to Beam? (2019) (3)
- Use of fixed-dose combination antihypertensives in Germany between 2016 and 2020: an example of guideline inertia (2022) (3)
- Intrathoracic impedance monitoring detecting pneumonia (2010) (3)
- Correction to: Rationale and design of two randomized sham‑controlled of catheter‑based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN‑OFF MED Pivotal) and presence (SPYRAL HTN‑ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian (2020) (3)
- Is there a role for renal sympathetic denervation in the future treatment of resistant hypertension? (2011) (3)
- Renal artery denervation via catheter-based delivery of low-power radiofrequency energy provides safe and durable blood pressure reduction: complete 3 year results from SYMPLICITY HTN-1 (2013) (3)
- Renal outcomes and blood pressure patterns in diabetic and nondiabetic individuals at high cardiovascular risk (2021) (3)
- Monday, 27 August 2012 (2012) (3)
- The blood pressure lowering effects of renal denervation in a real world population of patients with uncontrolled hypertension: early outcomes from the Global SYMPLICITY registry (2013) (3)
- CLINICAL EVENT REDUCTIONS IN HIGH-RISK HYPERTENSION PATIENTS TREATED WITH RENAL DENERVATION: A MODEL-BASED ESTIMATE BASED ON 36-MONTH DATA FROM THE GLOBAL SYMPLICITY REGISTRY (2021) (3)
- New Perspectives for Hypertension Management: Progress in Methodological and Technological Developments. (2022) (3)
- Histological evidence supporting the durability of successful radiofrequency renal denervation in a normotensive porcine model (2022) (3)
- A Physiologically Based Pharmacokinetic and Pharmacodynamic Model of the CYP3A4 Substrate Felodipine for Drug–Drug Interaction Modeling (2022) (3)
- Treatment resistant hypertension and renal sympathetic denervation: drug adherence and the consolidation of blood pressure lowering effects. (2013) (3)
- Development and implementation of blood pressure screening and referral guidelines for German community pharmacists (2020) (3)
- TCT-14 Effects of renal sympathetic denervation on heart rate and atrioventricular conduction in patients with resistant hypertension (2012) (3)
- Comparison of branch and distally focused main renal artery denervation using two different radio-frequency systems in a porcine model. (2017) (3)
- CHEMICAL RENAL DENERVATION WITH ALCOHOL – LONG TERM RESULTS FROM THE PEREGRINE POST-MARKET STUDY (2018) (3)
- Hotline sessions and clinical trial updates presented at the European Society of Cardiology Congress in Stockholm 2010 (2010) (3)
- Reduction of Outflow Tract Obstruction After PCI to Proximal LAD in a Patient With HOCM (2020) (3)
- Hypertension: Arteriovenous anastomosis—next panacea for hypertension? (2015) (3)
- Renal denervation reloaded: where to go from here? (2015) (3)
- Renal denervation reduces left ventricular mass in patients with resistant hypertension - results from a multicenter CMR-study (2013) (3)
- Study Evaluating the Use of RenalGuard to Protect Patients at High Risk of AKI. (2022) (3)
- Variability of ventricular repolarization during hypoglycemia. (2011) (2)
- Experimental Evidence Of The Role Of Renal Sympathetic Denervation For Treating Atrial Fibrillation. (2014) (2)
- Renal denervation in patients with heart failure with preserved ejection fraction: end of the beginning? (2016) (2)
- Effects of Medical Face Masks on Physical Performance in Patients With Coronary Artery Disease or Hypertension. (2022) (2)
- TCT-402 Renal Norepinephrine Reduction Following Radiofrequency Renal Denervation Correlates with Extent of Nerve Ablation: Roles of Ablation Areas, Anatomy, and Number of Treatments (2014) (2)
- TCT-29 Procedural and anatomic predictors of response in RADIANCE-HTN SOLO: a multicenter, randomized, sham-controlled trial of endovascular ultrasound renal denervation (2018) (2)
- sST2 is a promising biomarker in hypertensive patients undergoing renal denervation (2020) (2)
- The current status of devices for the treatment of resistant hypertension. (2019) (2)
- CRT-600.15 Safety and Performance Of Diagnostic Electrical Mapping of Renal Nerves in Hypertensive Patients and/or Potential Candidates for a Renal Sympathetic Denervation (RDN) Procedure (2018) (2)
- CONFIDENHTTM SYSTEM SAFETY AND PERFORMANCE OF DIAGNOSTIC ELECTRICAL MAPPING OF RENAL NERVES FOR RENAL SYMPATHETIC DENERVATION PROCEDURE (2018) (2)
- Changes in blood pressure after crossover to ultrasound renal denervation in patients initially treated with sham in the RADIANCE-HTN SOLO trial. (2021) (2)
- TCT-84 Renal Denervation With Symplicity Spyral Catheter in the Global Symplicity Registry: Safety and Efficacy at 3 Years (2019) (2)
- Hypertension management in patients with cardiovascular comorbidities. (2022) (2)
- Comparison of unilateral versus bilateral renal denervation in patients with resistant hypertension (2013) (2)
- Clinical and Procedural Outcomes of Renal Artery Denervation In Real World Patients with Hypertension: An Update From the Global SYMPLICITY Registry (2013) (2)
- Renal denervation: dark past, bright future? (2019) (2)
- 8B.04: RENAL ARTERY DENERVATION FOR TREATMENT OF HYPERTENSIVE PATIENTS WITH OR WITHOUT OBSTRUCTIVE SLEEP APNEA AND RESISTANT HYPERTENSION RESULTS FROM THE GLOBAL SYMPLICITY REGISTRY (2015) (2)
- Abstract 092: Global SYMPLICITY Registry: 3 Year Safety and Efficacy Data (2017) (2)
- Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the Global SYMPLICITY Registry. (2016) (2)
- Renal Denervation Prevents Atrial Arrhythmogenic Substrate Development in CKD (2022) (2)
- RADIANCE-HTN SOLO: A MULTICENTER, RANDOMIZED, SHAM-CONTROLLED STUDY OF RENAL DENERVATION IN PATIENTS WITH UNCONTROLLED HYPERTENSION IN THE ABSENCE OF ANTIHYPERTENSIVE MEDICATIONS (2018) (2)
- 4123Long term effect of transvenous carotid body ablation in the treatment of patients with resistant hypertension (2017) (2)
- Catheter-based renal denervation: Back on track? (2018) (2)
- High blood pressure in coronary artery disease: when to start treating and what to target? (2018) (2)
- 311 FEASIBILITY OF CATHETER-BASED RENAL DENERVATION AND EFFECTS ON SYMPATHETIC NERVE ACTIVITY AND BLOOD PRESSURE IN PATIENTS WITH END-STAGE RENAL DISEASE (2012) (2)
- Empagliflozin, irrespective of blood pressure, improves outcomes in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial (2022) (2)
- Predictors of blood pressure response after renal denervation beyond pretreatment blood pressure (2021) (2)
- Association between exercise frequency with renal and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk (2022) (2)
- Immediate and long-term impact of the COVID-19 pandemic on cardiovascular clinical trials: considerations for study conduct and endpoint determination. (2020) (2)
- ANATOMICAL AND PROCEDURAL DETERMINANTS OF CATHETER-BASED RENAL DENERVATION (2016) (2)
- TREATMENT-BLINDED MEDICATION TITRATION FOR HYPERTENSION CONTROL FOLLOWING RANDOMIZATION TO ENDOVASCULAR ULTRASOUND RENAL DENERVATION OR A SHAM PROCEDURE (2019) (2)
- Will SPYRAL HTN-OFF MED change my practice? SPYRAL HTN-OFF MED: a prospective, randomised, sham-controlled trial on renal denervation in the absence of antihypertensive medications. (2018) (2)
- Renal nerve ablation for treatment of therapy-resistant hypertension. (2013) (2)
- Will SPYRAL HTN-ON MED change my practice? SPYRAL HTN-ON MED: a prospective, randomised, sham-controlled trial on renal denervation in the presence of antihypertensive medications. (2018) (2)
- Trends in Ezetimibe Prescriptions as Monotherapy or Fixed-Dose Combination in Germany 2012–2021 (2022) (2)
- Extra‐cardiac targets in the management of cardiometabolic disease: Device‐based therapies (2021) (2)
- Drug therapy for the patient with resistant hypertension. (2015) (2)
- Using social media to recruit study participants for a randomized trial for hypertension (2020) (2)
- Effects of renal denervation on heart failure biomarkers and blood pressure in patients with resistant hypertension. (2016) (2)
- Results from a multicenter CMR-study in patients with resistant hypertension - pre and post renal denervation (2013) (2)
- Do patients with diabetes type 2 or chronic heart failure understand a medication plan? (2017) (2)
- Will SPRINT change my practice? SPRINT: a randomised trial of intensive versus standard blood-pressure control. (2016) (2)
- Alcohol-mediated renal sympathetic neurolysis for the treatment of hypertension: The Peregrine™ infusion catheter. (2020) (2)
- Response to letter regarding article, "ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension". (2014) (2)
- Clinical Event Reductions in High-Risk Patients After Renal Denervation Projected from the Global SYMPLICITY Registry. (2022) (2)
- Renal artery variations in patients with mild-to-moderate hypertension from the RADIANCE-HTN SOLO trial. (2021) (2)
- [Renal denervation in refractory hypertension: joint statement of the German hypertension league DHL eV and the German societies of cardiology, angiology, nephrology and radiology]. (2015) (2)
- Sex Differences in Cardiovascular Research: A Scientometric Analysis (2021) (2)
- Application in Hypertension of Renal Sympathetic Denervation - A Review. (2013) (1)
- Transluminal Imaging of Renal Nerves using Optical Coherence Tomography (2014) (1)
- Global longitudinal strain differentiates physiological hypertrophy from maladaptive remodeling (2022) (1)
- Pacemaker‐Based Cardiac Neuromodulation Therapy for the Treatment of Hypertension: The New Kid on the Block (2021) (1)
- Procedural parameters during renal denervation and change of blood pressure in patients with resistant hypertension (2013) (1)
- SUBGROUP ANALYSIS OF LONG-TERM BLOOD PRESSURE REDUCTION IN THE GLOBAL SYMPLICITY REGISTRY (2019) (1)
- Inducibility of atrial fibrillation after catheter ablation predicts recurrences of atrial fibrillation: a meta‐analysis (2021) (1)
- Risk prediction with blood pressure during physical activity: A METter of exercise? (2020) (1)
- Proof of concept : direct vascular protective effects of renin – angiotensin system inhibition (2009) (1)
- Response to Letter Regarding Article, “Effect of Renal Sympathetic Denervation on Glucose Metabolism in Patients With Resistant Hypertension: A Pilot Study” (2011) (1)
- Tuesday, 28 August 2012 (2012) (1)
- Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI). (2023) (1)
- PCV64 IMPACT ON ANTIHYPERTENSIVE PRESCRIBING AFTER THE DEAR HEALTHCARE PROFESSIONAL LETTER ON INCREASED RISK OF SKIN CANCER RELATED TO HYDROCHLOROTHIAZIDE (2020) (1)
- The European Heart Journal and EuroIntervention: information and education in interventional cardiology. (2013) (1)
- Response to letter regarding article, "renal denervation for the treatment of cardiovascular high risk-hypertension or beyond?". (2014) (1)
- Cardiovascular outcomes in patients at high cardiovascular risk with previous myocardial infarction or stroke (2021) (1)
- Will ORBITA change my practice? ORBITA trial: Objective Randomised Blinded Investigation with optimal medical Therapy of Angioplasty in stable angina. (2018) (1)
- Atrial Autonomic Innervation (1)
- Risk prediction with office and ambulatory blood pressure using artificial intelligence (2020) (1)
- Arterial hypertension - clinical trials update 2022 (2022) (1)
- 650Implanted cardioverter defibrillator (ICD) therapy in patients with suspected myocarditis: time of implantation and occurrence of ventricular arrhythmias (2017) (1)
- Abstract 18179: Catheter-Based Renal Denervation Reduces Left Ventricular Mass in Patients with Resistant Hypertension - Results from a Multicenter Study (2012) (1)
- Renal Denervation in Daily Practice: If So, How? (2020) (1)
- Renal denervation for the treatment of ventricular arrhythmias: A systematic review and meta‐analysis (2021) (1)
- Combined Analysis of Two Parallel Randomized Trials of Sirolimus-Coated and Paclitaxel-Coated Balloons in Coronary In-Stent Restenosis Lesions (2022) (1)
- Pathophysiology: The Target for Renal Denervation (2015) (1)
- Meta-analysis in renal denervation - Or how to compare apples with oranges? (2021) (1)
- Endovascular Ultrasound Renal Denervation to Treat Hypertension: The RADIANCE II Randomized Clinical Trial. (2023) (1)
- TCT CONNECT-417 Impact of Renal Denervation on Plasma Renin Activity and Relationship of Baseline Plasma Renin Activity to Blood Pressure Lowering Response to Renal Denervation in the SPYRAL HTN-OFF MED Pivotal trial (2020) (1)
- Abstract 109: Changes in Plasma Renin Activity After Renal Denervation in the Spyral Htn-Off Med Trial (2019) (1)
- Abstract 070: Adherence to Antihypertensive Drugs: Insights from the SPYRAL HTN Trials and Implications for Hypertension Trial Design (2018) (1)
- Reductions of left-ventricular mass and improvements in left-ventricular diastolic function following renal denervation do not correlate with blood pressure or heart rate reduction (2013) (1)
- LB02.02: EFFECT OF ARTERIOVENOUS ANASTOMOSIS ON BLOOD PRESSURE REDUCTION IN PATIENTS WITH ISOLATED SYSTOLIC HYPERTENSION COMPARED TO COMBINED HYPERTENSION (2015) (1)
- TCT-762 Renal denervation treatment with the Symplicity Spyral multielectrode catheter: 6-month safety and blood pressure outcomes from the Global SYMPLICITY Registry. (2016) (1)
- Cardiac remodeling and myocardial dysfunction in obese spontaneously hypertensive rats (2012) (1)
- A drug-induced hypotensive challenge to verify catheter-based radiofrequency renal denervation in an obese hypertensive swine model (2020) (1)
- TCT-19 Durability of Radio-Frequency Catheter-Based Renal Denervation Associated With Lack of Functional Nerve Recovery at 6 Months in Normotensive Swine Model (2021) (1)
- Renal Denervation prevents subclinical atrial fibrillation in patients with hypertensive heart disease: randomized, sham-controlled trial. (2022) (1)
- Renal denervation attenuates impairment of renal function and kidney injury in obese spontaneously hypertensive rats (2013) (1)
- Levoatrial-to-Coronary Sinus Shunting in Heart Failure Therapy: Getting Off the Beaten Track? (2020) (1)
- Cardio-renal interaction - Clinical trials update 2022. (2022) (1)
- Prediction of conduction disturbances in patients undergoing transcatheter aortic valve replacement (2023) (1)
- Impact of drug adherence on blood pressure response to alcohol-mediated renal denervation (2022) (1)
- CRT-608 Pooled 3-Year Symplicity Htn-1 and Symplicity Htn-2 Results and Diabetes Subgroup Analysis (2014) (1)
- A re-examination of the SPYRAL HTN-OFF MED Pivotal trial with respect to the underlying model assumptions (2021) (1)
- [Renal denervation in hypertension - pro]. (2012) (1)
- Renal Artery Denervation (2014) (1)
- The ''RADIANCE-HTN'' clinical study: a two-cohort study design to evaluate the effectiveness of the paradise renal denervation system in patients with hypertension (2016) (1)
- CRT-200.22 Safety And Efficacy Of Renal Sympathetic Denervation Using Circumferential Ultrasound: 12-month Results of the ACHIEVE Study (2018) (1)
- Myocardial infarction in a patient with single coronary artery - rare but real. (2020) (1)
- TCT-32 ConfidenHT™ system - diagnostic electrical mapping of renal nerves for optimizing renal denervation procedures (2018) (1)
- Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials. (2023) (1)
- Sex differences in cardiovascular research (2021) (1)
- Aorticorenal Ganglia Pacing: A Step Forward in Unblinding Renal Denervation Procedures? (2019) (1)
- 1199Reduction in blood pressure following renal denervation for patients with differing baseline cardiovascular risk (2019) (0)
- Data at 36 months for the Symplicity SPYRAL HTN-ON MED pilot – Authors' reply (2022) (0)
- NONINVASIVE 24-HOUR HEMODYNAMICS PREDICT BLOOD PRESSURE RESPONSE TO RENAL DENERVATION IN THE SPYRAL HTN-OFF MED PILOT AND PIVOTAL TRIALS (2021) (0)
- Results of the multicenter, prospective, randomised STRENGTH (Study To evaluate the use of RENalGuard to proTect patients at High risk of acute kidney injury) study (2020) (0)
- First-in-man experience with ultrasound renal denervation for treatment of recurrent ventricular arrhythmias (2020) (0)
- CARDIORESPIRATORY RESPONSE TO EXERCISE AFTER RENAL SYMPATHETIC DENERVATION IN PATIENTS WITH RESISTANT HYPERTENSION: 4A.10 (2011) (0)
- Correction to: One‑year clinical outcomes in patients with renal insuffciency after contemporary PCI: data from a multicenter registry (2020) (0)
- CHEMICAL RENAL DENERVATION WITH ALCOHOL – THE POST-MARKET STUDY MEDICATION ADHERENCE DATA (2019) (0)
- Renal sympathetic denervation inhibits postapneic blood pressure rises and renal hypoperfusion in a pig model for obstructive sleep apnea (2013) (0)
- Oral Abstract Session: Translational view on atrial fibrillation (2013) (0)
- Morphometric analysis of the human common hepatic artery reveals a rich and accessible target for sympathetic liver denervation (2022) (0)
- P3208Regulation of cardiac ADAM-10 activity by sympathoadrenergic modulation and the role for RAGE-sRAGE balance and myocardial remodeling (2018) (0)
- Catheter-based renal denervation: treating hypertension or beyond? (2014) (0)
- TCT-768 Comparative Branch And Distally Focused Main Renal Artery Denervation With Two Radio Frequency Catheters In A Preclinical Model (2015) (0)
- Reply letter to: 'Ventricular arrhythmias and myocardial inflammation detection methods'. (2019) (0)
- TCT-536 Impact of Transcatheter Aortic Valve Replacement on His-Ventricular Interval (2019) (0)
- TCT-212 Twenty-Four Month Results in Patients With Resistant Hypertension After Endovascular Ultrasound Renal Denervation in the RADIANCE-HTN TRIO Trial (2022) (0)
- TCT-547 Sham-Controlled Trials of Invasive Cardiovascular Interventions: A Systematic Review and Meta-Analysis (2019) (0)
- Hypertension urgencies in the SPYRAL HTN-OFF MED Pivotal trial (2022) (0)
- [Current aspects of heart-kidney interactions : Summary of important clinical studies from 2020]. (2021) (0)
- Quantitative coronary three-dimensional geometry and its association with atherosclerotic disease burden and composition. (2023) (0)
- [Preoperative cardiovascular risk evaluation before elective noncardiac surgical interventions]. (2020) (0)
- Model-Based Analysis of SARS-CoV-2 Infections, Hospitalization and Outcome in Germany, the Federal States and Districts (2022) (0)
- RENAL DENERVATION REDUCES CENTRAL SYMPATHETIC DRIVE AND IMPROVES INSULIN SENSITIVITY IN PCOS: PP.26.311 (2011) (0)
- Efficacy of Antihypertensive Drugs of Different Classes After Renal Denervation in Spontaneously Hypertensive Rats. (2023) (0)
- TCT-562 Chemical Renal Denervation With Alcohol – The Post-Market Study Data And The Target BP Program (2018) (0)
- Results Clinical Observations : Effect of RDN in a Patient With Resistant Hypertension and Previous RA Stenting (2014) (0)
- Durability of Radiofrequency Catheter-Based Renal Denervation in Normotensive Swine (2022) (0)
- [Interventional hypertension therapy in diabetes mellitus. Effects on blood pressure and glucose metabolism?]. (2014) (0)
- A-34 | Renal Denervation Increases Time in Target Range Compared to Sham Control in the Presence of Antihypertension Drugs (2022) (0)
- Reply to 'Meta-analyses in hypertension: simple mathematics are always welcome'. (2020) (0)
- IMPACT OF RENAL DENERVATION ON PLASMA RENIN ACTIVITY AND RELATIONSHIP OF BASELINE PLASMA RENIN ACTIVITY TO BLOOD PRESSURE LOWERING RESPONSE TO RENAL DENERVATION IN THE SPYRAL HTN-OFF MED PIVOTAL TRIAL (2020) (0)
- Mahfoud et al Aldosterone Antagonists and RDN — Friends or Foes ? (0)
- EFFECTS OF RENAL DENERVATION IN PATIENTS WITH VERSUS WITHOUT CHRONIC KIDNEY DISEASE (2019) (0)
- Catheter-based Renal Denervation for Therapy of Hypertension: Is There a Hope for Its Resurgence? (2015) (0)
- OS 28-03 SECRETORY CAPACITY OF PANCREATIC BETA CELLS IS ENHANCED 6 MONTHS AFTER RENAL DENERVATION IN TREATMENT RESISTANT HYPERTENSIVE PATIENTS. (2016) (0)
- P5369The effect of a hypotensive challenge before and after catheter-based radio-frequency renal nerve denervation in obese hypertensive swine model (2018) (0)
- Alterations in cardiovascular physiology in pathological states (2018) (0)
- Side effects and treatment initiation barriers of SGLT2 inhibitors in heart failure: A systematic review and meta-analysis. (2022) (0)
- IMPROVEMENT OF ALBUMINURIA AFTER RENAL DENERVATION (2014) (0)
- Procedural Aspects of Renal Sympathetic Denervation (2016) (0)
- Diabetes and Metabolic Syndrome (2015) (0)
- Renal Denervation for Resistant Hypertension (2016) (0)
- Modulation of the sympathetic nervous system by renal denervation prevents reduction of aortic distensibility in atherosclerosis prone ApoE-deficient rats (2016) (0)
- Ambulatory blood pressure changes and predictors of response in patients undergoing renal sympathetic denervation (2013) (0)
- TCT-211 Home Blood Pressure Response to Ultrasound Renal Denervation—A Patient-Level Pooled Analysis of the RADIANCE-HTN SOLO and TRIO Randomised, Sham-Controlled Trials (2022) (0)
- P2405Echocardiographic criteria to detect unicuspid aortic valve morphology (2017) (0)
- HOW EFFECTIVE IS RENAL DENERVATION IN LESS SEVERE TREATMENT RESISTANT HYPERTENSION (2013) (0)
- Resistant Hypertension Ambulatory Blood Pressure Changes after Renal Sympathetic Denervation in Patients with (2013) (0)
- Photo-induced skin reactions of cardiovascular drugs - a systematic review. (2022) (0)
- LONG-TERM RESULTS FROM THE SPYRAL HTN-ON MED TRIAL: RENAL DENERVATION INCREASES TIME IN BLOOD PRESSURE TARGET RANGE OVER 36 MONTHS (2022) (0)
- Association of hydrochlorothiazide treatment compared with alternative diuretics with overall and skin cancer risk: a propensity-matched cohort study (2023) (0)
- RENAL SYMPATHETIC DENERVATION FOR TREATMENT OF DRUG-RESISTANT HYPERTENSION IN AN ASIAN POPULATION: RESULTS FROM THE GLOBAL SYMPLICITY REGISTRY IN SOUTH KOREA (GSR KOREA) AND COMPARISON TO SYMPLICITY HTN-2 (2015) (0)
- P3594Interventional patent foramen ovale closure or medical therapy only for the prevention of recurrent strokes: A meta analysis of available randomized trials (2018) (0)
- [PP.10.14] THE EFFECT OF RENAL DENERVATION IN MODERATE TREATMENT RESISTANT HYPERTENSION WITH CONFIRMED MEDICATION ADHERENCE (2016) (0)
- Closing the gap — development of an analytical methodology using volumetric absorptive microsampling of finger prick blood followed by LC-HRMS/MS for adherence monitoring of antihypertensive drugs (2022) (0)
- Ischemic Stroke–A Scientometric Analysis (2022) (0)
- Application of win ratio methodology in the Global SYMPLICITY Registry for patients with atrial fibrillation or obstructive sleep apnea (2021) (0)
- Target blood pressure in high risk cardiovascular patients. (2017) (0)
- Morphometric analysis of the human common hepatic artery reveals a rich and accessible target for sympathetic liver denervation (2022) (0)
- 10-Year Outcomes of Catheter-Based Renal Denervation in Patients With Resistant Hypertension. (2023) (0)
- Liver stiffness as surrogate parameter in emergency assessment for inpatient health care utilization (2022) (0)
- Renal denervation reduces atrial remodeling in hypertensive rats with metabolic syndrome (2022) (0)
- Off-the-shelf barrier for emergency intubation in the cardiac catheterization laboratory during the coronavirus disease 2019 (COVID-19) pandemic (2020) (0)
- [Renal insufficiency in the context of cardio-pulmonary-renal pathophysiology]. (2021) (0)
- [Cardiopulmonary interactions: cardiovascular diseases and chronic obstructive pulmonary disease]. (2009) (0)
- The Role of Renal Denervation (2013) (0)
- Kardiale Resynchronisationstherapie: Präoperatives Screening (2009) (0)
- Abstract 13281: Effect of Arteriovenous Anastomosis on Blood Pressure Reduction in Patients With Isolated Systolic Hypertension Compared to Combined Hypertension (2015) (0)
- Comparison of Bright Blood and Black Blood Retrospectively Self-gated CINE Sequences for the Assessment of Aortic Distensibility in Rats at 9.4 Tesla (2014) (0)
- Impact of atrial flow regulator implantation on survival in patients with heart failure with reduced and preserved ejection fraction: a post-hoc analysis of the PRELIEVE study (2022) (0)
- LIVER STIFFNESS MEASUREMENTS IN EMERGENCY TRIAGE PREDICT INPATIENT HEALTH CARE UTILIZATION (2021) (0)
- Fifty Years of Global Cardiovascular Research in Africa: A Scientometric Analysis, 1971 to 2021 (2023) (0)
- Editorial: Uncontrolled Hypertension and Related Comorbidities: A Clinician's Update. (2017) (0)
- TCT-211 Ambulatory blood pressure and dipping-pattern after catheter-based renal sympathetic denervation in patients with resistant hypertension (2012) (0)
- [OP.7A.01] THE GLOBAL SYMPLICITY REGISTRY: SAFETY AND EFFICACY REPORT (2017) (0)
- Abstract P203: Insights To Lesion Formation For Percutaneous Renal Denervation: Human And Porcine Histological Analyses (2020) (0)
- Differences in management of telemedicine alerts on weekdays and public holidays: Results from the OptiLink heart failure trial. (2021) (0)
- Radial pseudoaneurysm following coronary angiography in a patient with autosomal dominant polycystic kidney disease (2023) (0)
- Hydrochlorothiazide does not lead to phototoxic reactions and DNA damage in healthy volunteers the HCTox study (2022) (0)
- EFFECT OF RENAL DENERVATION IN ATTENUATING THE MORNING SURGE IN BLOOD PRESSURE (2019) (0)
- Device-based treatment for hypertension (2018) (0)
- Medication Adherence in Hypertension: Lessons Learned from Renal Denervation Trials. (2022) (0)
- Correction to: Off‑the‑shelf barrier for emergency intubation in the cardiac catheterization laboratory during the coronavirus disease 2019 (COVID‑19) pandemic (2020) (0)
- A decade of experience with DES Insights from large registries and randomised clinical trials (2013) (0)
- Contents (2020) (0)
- [LB.02.04] EFFECTS OF RENAL DENERVATION IN PATIENTS WITH VERSUS WITHOUT CHRONIC KIDNEY DISEASE: RESULTS FROM THE GLOBAL SYMPLICITY REGISTRY WITH FOLLOW-UP DATA OF 3 YEARS (2017) (0)
- [Cardiac resynchronization therapy: preoperative screening. How can we reliably predict response to CRT?]. (2009) (0)
- TCT CONNECT-419 Patients With Resistant Hypertension in the Global SYMPLICITY Registry: Antihypertensive Medication Burden and Changes in Blood Pressure out to 3 Years (2020) (0)
- J-curve revisited. (2020) (0)
- P5266Renal denervation improves diastolic dysfunction in patients with HFpEF - initial results of a multicenter CMR study (2019) (0)
- TCT-83 Effects of Catheter-Based Renal Denervation on Left Ventricular Function Assessed by 2-Dimensional Speckle Tracking Echocardiography (2019) (0)
- Considering a New Approach to Treatment of Uncontrolled Hypertension With the ROX Coupler Device (2018) (0)
- PS 14-63 THE EFFECT OF RENAL DENERVATION IN MODERATE TREATMENT RESISTANT HYPERTENSION WITH CONFIRMED MEDICATION ADHERENCE (2016) (0)
- S-35-6: LONG-TERM REDUCTION IN MORNING AND NIGHTTIME BLOOD PRESSURE AFTER RENAL DENERVATION: 36-MONTH RESULTS FROM SPYRAL HTN-ON MED PILOT TRIAL (2023) (0)
- Effects of Renal Denervation vs Sham in Resistant Hypertension After Medication Escalation (2022) (0)
- Percutaneous renal denervation through a false lumen fenestration in aortic dissection type B (2013) (0)
- Cardiopulmonary interactions: Cardiovasculardiseases and chronic obstructive pulmonary disease (2009) (0)
- [Selecting the right patient for renal denervation]. (2013) (0)
- Experts Examine Recent Developments in Interventional Cardiology (2015) (0)
- Prevalence of ICD therapy in patients with suspected myocarditis (2013) (0)
- P5442The non-steroidal mineralocorticoid receptor antagonist finerenone prevents structural cardiac remodeling (2019) (0)
- Effects of surgical and FFP2 masks on cardiopulmonary exercise capacity in patients with heart failure (2022) (0)
- Plasma biomarkers outperform echocardiographic measurements for cardiovascular risk prediction in kidney transplant recipients: results of the HOME ALONE study (2021) (0)
- TCT-425 Innervation Patterns in the Renal Artery Ostium May Limit the Efficacy of Endovascular Radiofrequency Ablation (2014) (0)
- Abstract P154: Win Ratio Methodology Demonstrates Consistency Of Benefit Across Different Blood Pressure Reduction Thresholds Following Renal Denervation In The Spyral Htn-on Med Pilot Study (2021) (0)
- Reply. (2019) (0)
- TCTAP A-002 Long-Term Safety and Efficacy of Renal Denervation in the Global Symplicity Registry Using the Symplicity Spyral Catheter (2023) (0)
- [Direct renin inhibition: a new and promising treatment principle in heart failure?]. (2009) (0)
- IMPACT OF GEOGRAPHICAL VARIATION BETWEEN EUROPE AND ASIA ON CLINICAL OUTCOMES IN PATIENTS WITH HIGH BLEEDING RISK (HBR) AND BIODEGRADABLE-POLYMER SIROLIMUSELUTING CORONARY STENT: A SUBSTUDY OF MASTER DAPT (2023) (0)
- TCT-608 Implementation of Bayesian Study Design in the SPYRAL HTN-OFF MED Pivotal Trial (2019) (0)
- Registration of Image Modalities for Analyses of Tissue Samples Using 3D Image Modelling. (2021) (0)
- Renal Denervation Induces Reverse‐Remodeling in MicroRNA: Just Blood Pressure Reduction or More? (2016) (0)
- Left ventricular longitudinal strain in professional athletes, a useful tool to detect an athletes hearts? (2020) (0)
- Correction: Arterial hypertension - clinical trials update 2022 (2022) (0)
- [Secondary prevention in a diabetic with myocardial infarction treated with a stent]. (2009) (0)
- 1420Peripheral edema and headache associated with amlodipine treatment: a meta-analysis of randomized, placebo-controlled trials (2019) (0)
- Primum non nocere: the dangers of deferring heart failure therapy (2017) (0)
- The Global SYMPLICITY Registry: Safety and Efficacy Report (2017) (0)
- [Cardiac diagnostic in hypertension]. (2014) (0)
- Interventionelle Hypertonietherapie bei Diabetes mellitus (2014) (0)
- Abstract 12684: Development and Implementation of Blood Pressure Screening and Referral Guidelines for Community Pharmacists (2020) (0)
- Schlaich, M. P. (2019). Renal Denervation Update From the International Sympathetic Nervous System Summit: JACC State-of- (2019) (0)
- Esler and Michael Böhm MurrayC (2011) (0)
- Arteriovenous fistula, blood pressure, and shunt flow: A thin line that separates beneficial from detrimental effects. (2019) (0)
- [Renal sympathetic denervation: still to follow after Symplicity HTN-3? Yes]. (2014) (0)
- P1210Psychosocial factors in patients with atrial fibrillation undergoing pulmonary vein isolation (2018) (0)
- TCT-559 Influence of Gender on Blood Pressure Reduction After Renal Denervation in GSR DEFINE (2022) (0)
- TCTAP A-048 Reduction of Clinical Events in High-Risk Hypertension Patients Treated With Renal Denervation: A Modeled Estimate From 36-Month Global SYMPLICTY Registry Data (2022) (0)
- Registries in renal denervation-completing the picture? (2020) (0)
- SUBGROUP ANALYSIS IN THE GLOBAL SYMPLICITY REGISTRY (2019) (0)
- Renal denervation reduces blood pressure and attenuates impairment of left ventricular compliance in obese spontaneously hypertensive rats (2013) (0)
- BLOOD PRESSURE REDUCTION AFTER CATHETER-BASED RENAL DENERVATION IN PATIENTS WITH CARDIOVASCULAR DISEASE IN THE GLOBAL SYMPLICITY REGISTRY (2022) (0)
- Time to benefit of heart rate reduction with ivabradine in patients with heart failure and reduced ejection fraction. (2023) (0)
- Handling of remote monitoring alerts according to the weekday of transmission: results from the OptiLink HF study (2020) (0)
- Adherence monitoring of antihypertensive drugs in finger prick blood microsamples – Development and validation of an analytical procedure (2022) (0)
- OS 28-03 SECRETORY CAPACITY OF PANCREATIC BETA CELLS IS ENHANCED 6 MONTHS AFTER RENAL DENERVATION IN TREATMENT RESISTANT HYPERTENSIVE PATIENTS (2016) (0)
- Glycyrrhizin through liquorice intake modulates ACE2 and HMGB1 levels—A pilot study in healthy individuals with implications for COVID-19 and ARDS (2022) (0)
- TCT-13 Renal resistive indices, urinary albumin excretion and renal function in patients with resistant hypertension after catheter-based renal sympathetic denervation (2012) (0)
- CRT-200.21 Alcohol-mediated Renal Denervation to Treat Hypertension- The Peregrine Post-market Study (2018) (0)
- Association of heart rate with heart failure outcomes and the effects of empagliflozin in patients with preserved ejection fraction – EMPEROR-Preserved trial (2022) (0)
- 16 Blood pressure reduction after catheter-based renal denervation in the absence of antihypertensive medications: spyral HTN-off med pivotal trial results (2020) (0)
- Renal denervation for treatment of hypertension - will 2017 be the year of enlightenment? (2017) (0)
- Using social media to recruit study participants for a randomised trial for hypertension (Preprint) (2020) (0)
- EuroPCR 2014, Hypertension and Heart Failure Track take-home messages. (2014) (0)
- Renal Denervation for the Treatment of Ventricular Arrhythmias: A Systematic Review and Meta-Analysis (2020) (0)
- Overestimation of cardiovascular outcome incidence – Authors' reply (2017) (0)
- Renal Denervation for Chronic Heart Failure (2016) (0)
- Translational value of preclinical models for renal denervation: a histological comparison of human versus porcine renal nerve anatomy. (2022) (0)
- Renal artery denervation affects the circulating microRNA profile in patients with resistant arterial hypertension (2013) (0)
- Dyspnea in a Diabetic Patient With Previous TAVR (2018) (0)
- Radiofrequency renal denervation is effective - and safe? (2020) (0)
- TCT-766 Sub-acute Safety and Efficacy Evaluation of a Single versus Double Treatment Cycles of a Monopolar Radiofrequency Catheter-Based Renal Nerve Ablation and its Chronic Evolution in a Large Animal Model (2015) (0)
- A-30 | Radio Frequency Renal Denervation has High Specificity for Renal Nerves with Minimal Observable Effects to the Non-Target Perivascular Tissue (2022) (0)
- Blood pressure lowering with alcohol‐mediated renal denervation using the Peregrine infusion Catheter is independent of injection site location (2021) (0)
- Apparent Non-Cited Overlap between Two Published Articles by the Same Group of Authors (2010) (0)
- TCT-81 Quantification of Procedural and Anatomical Determinants of Multielectrode Renal Denervation (2019) (0)
- A4699 Effects of renal denervation in patients with versus without chronic kidney disease: results from the Global Symplicity Registry with follow-up data of 3 years (2018) (0)
- [Blood pressure targets in patients with diabetes mellitus : What are optimum values?] (2019) (0)
- Blood pressure reduction in higher cardiovascular risk patients in the Global SYMPLICITY Registry (2022) (0)
- Renal denervation improves left ventricular efficiency by reducing afterload and contractility while increasing diastolic capacity - results of single beat pressure volume analysis (2013) (0)
- , Renal Denervation in Patients With Resistant Hypertension Blood Pressure Response to Main Renal Artery and Combined Main Renal Artery Plus Branch (2017) (0)
- Troubleshooting of a left common carotid artery pseudoaneurysm as complication of central venous catheter placement (2021) (0)
- TCT CONNECT-418 Evaluation of Nerve Injury and Regrowth Following Renal Denervation in Swine Model (2020) (0)
- Reply: Sympathetic and Autonomic Effects of Renal Denervation on Atrial Remodeling and Atrial Arrhythmias. (2015) (0)
- PS-C19-3: HYDROCHLOROTHIAZIDE WAS NOT ASSOCIATED WITH PHOTOSENSITIVE OR PHOTOTOXIC REACTIONS AND DNA-DAMAGE IN VIVO AND IN VITRO (THE HCTOX-STUDY) (2023) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Felix Mahfoud?
Felix Mahfoud is affiliated with the following schools:
